Skip to main navigation Skip to search Skip to main content

Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial

  • Byeong Ho Park
  • , Taeho Hwang
  • , Ta Chiang Liu
  • , Daniel Y. Sze
  • , Jae Seok Kim
  • , Hyuk Chan Kwon
  • , Sung Yong Oh
  • , Sang Young Han
  • , Jin Han Yoon
  • , Sook Hee Hong
  • , Anne Moon
  • , Kelly Speth
  • , Chohee Park
  • , Young Joo Ahn
  • , Manijeh Daneshmand
  • , Byung Geon Rhee
  • , Herbert M. Pinedo
  • , John C. Bell
  • , David H. Kirn

Research output: Contribution to journal › Article › peer-review

353   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Biochemistry, Genetics and Molecular Biology